Home/Filings/4/0001689375-24-000028
4//SEC Filing

KIM PETER S 4

Accession 0001689375-24-000028

CIK 0001689375other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 4:35 PM ET

Size

7.0 KB

Accession

0001689375-24-000028

Insider Transaction Report

Form 4
Period: 2024-05-08
KIM PETER S
Director
Transactions
  • Purchase

    Common Stock

    2024-05-08$14.04/sh+2,276$31,96565,212 total
  • Purchase

    Common Stock

    2024-05-09$14.25/sh+2,200$31,34167,412 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.81 to $14.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.11 to $14.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

Entrada Therapeutics, Inc.

CIK 0001689375

Entity typeother

Related Parties

1
  • filerCIK 0001181180

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:35 PM ET
Size
7.0 KB